Fap Il2v Eih With A Dose Escalation Followed By Expansion
Research payments
$1,252,780
Through program year 2023, $1,252,780 in research payments was reported against Fap Il2v Eih With A Dose Escalation Followed By Expansion, across 66 payments, paid by Genentech, Inc..
- Paid by
- Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $43,496 | 5 |
| 2022 | Research | $160,502 | 11 |
| 2021 | Research | $523,037 | 22 |
| 2020 | Research | $414,003 | 16 |
| 2019 | Research | $111,742 | 12 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Julie Bauman Albuquerque, NM Named on 22 payments
- Jiaxin Niu Gilbert, AZ Named on 9 payments
- Daruka Mahadevan Tucson, AZ Named on 8 payments
- Pavani Chalasani Tucson, AZ Named on 7 payments
- Marcelo Bonomi Columbus, OH Named on 6 payments
- Christopher Klebanoff New York, NY Named on 3 payments
- Sandip Patel La Jolla, CA Named on 2 payments
- Douglas Adkins Saint Louis, MO Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.